Tevogen Bio to Develop T Cell Therapies for Treatment of Epstein-Barr Virus Related Cancers and Multiple Sclerosis
Tevogen Bio, a late-stage clinical biotechnology company specializing in the development of cellular immunotherapies in…More
Tevogen Bio, a late-stage clinical biotechnology company specializing in the development of cellular immunotherapies in…More
Celularity, Inc. (Nasdaq: CELU) (“Celularity” or “the Company”), a clinical-stage biotechnology company developing placental-derived allogenic…More
Aster Guardians Global Nursing Award, an initiative by leading healthcare provider Aster DM Healthcare to…More
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces a new exclusive licensing agreements with Celltrion…More
Aster DM Healthcare, one of the largest integrated healthcare providers in the GCC and India,…More
Abu Dhabi, United Arab Emirates: Beyond2020, the UAE-driven humanitarian initiative, has expanded its global reach…More
DUBAI, United Arab Emirates — KRBL Limited has been selected as one of the winners…More
DUBAI, United Arab Emirates — Johnson’s Baby is launching its first Baby Expo – a…More
RIYADH, Saudi Arabia — The Middle East’s digital health transformation will be at the top…More
Dubai, United Arab Emirates — Today, customers are looking for new ways to use video…More
DUBAI, United Arab Emirates — Direct selling company, QNET, showcased its sustainability initiatives, including its…More
LONDON — C. & J. Clark International Ltd (“Clarks”) and some of its subsidiaries has announced…More